Skip to main content

Exploring Nutritional Supplements for ADHD: Evidence-Based Insights and Recommendations

Written by Andrew Le, MD

UpdatedAugust 29, 2024

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common condition that affects many school-aged children, making it difficult for them to focus, control impulses, and stay organized. While traditional medications like stimulants are effective for over 70% of children with ADHD, concerns about potential side effects and long-term effects often lead families to explore alternative treatments.

These alternatives include natural supplements, which are used by a significant portion of children with ADHD despite a less robust evidence base compared to conventional treatments.

In this article, we will explore the potential benefits and risks of various supplements used for ADHD and review the scientific evidence behind these treatments, helping you make informed decisions about their use.

Polyunsaturated Fatty Acids (PUFAs)

Polyunsaturated fatty acids (PUFAs), particularly omega-3 and omega-6 fatty acids, have been extensively studied as potential complementary treatments for ADHD. These essential fatty acids play a crucial role in brain function and development, and their imbalance may contribute to the symptoms of ADHD.

The Role of Omega-3 Fatty Acids in ADHD

Omega-3 fatty acids, found primarily in fish oils, are known for their anti-inflammatory properties. They have been hypothesized to improve ADHD symptoms by influencing neurotransmitter function, particularly in the frontal cortex, which is a crucial area of the brain affected by ADHD.

Specifically, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the main components of omega-3 fatty acids studied concerning ADHD. Increasing the intake of these fatty acids is thought to help correct neurochemical imbalances in children with ADHD, potentially reducing symptoms.

Evidence from Clinical Trials on PUFA Supplementation

Research into the effectiveness of PUFA supplementation in ADHD has yielded mixed results. An initial meta-analysis involving ten trials and 699 children with ADHD found a statistically significant benefit of PUFA supplementation compared to placebo.

However, the effect size was smaller than that of traditional ADHD medication. This analysis also highlighted that formulations with higher EPA content appeared more effective in improving ADHD symptoms.

Further systematic reviews confirmed these findings, supporting the efficacy of PUFA supplementation for ADHD symptoms. However, two recent reviews raised questions about the overall benefits of omega-3 supplementation. One Cochrane review did not find a significant benefit of omega-3 on most ADHD outcome measures, citing methodological differences as a potential reason for the varied results.

Another review identified possible publication bias, although this was partly attributed to including trials involving children with other primary disorders, such as dyslexia, where the benefits of PUFA supplementation might be less pronounced.

Dosage Recommendations

Based on the cumulative evidence, omega-3 fatty acid supplementation is recommended at 1–2 grams daily, with a substantial content of EPA. This dosage has shown benefits in treating ADHD symptoms, although the effects are modest compared to those achieved with traditional medications.

It's important to note that omega-3 supplementation may be beneficial in children with mild ADHD or as an adjunctive treatment in more severe cases.

Melatonin

Children with ADHD often experience significant sleep issues, such as difficulty falling asleep, which can exacerbate their symptoms during the day. Melatonin, a hormone that regulates sleep-wake cycles, is commonly used to address these sleep disturbances.

The Effectiveness of Melatonin in ADHD-Related Sleep Disorders

Melatonin has been studied for its effectiveness in treating sleep-onset insomnia in children with ADHD. Randomized placebo-controlled trials have demonstrated that melatonin can significantly decrease the time it takes for children with ADHD to fall asleep. In one trial, children with ADHD and sleep-onset insomnia who were treated with melatonin showed a reduction in sleep latency, meaning they fell asleep faster.

However, these studies did not find any significant impact of melatonin on core ADHD symptoms. This suggests that while melatonin may help children with ADHD get to sleep more quickly, it does not directly improve attention, hyperactivity, or impulsivity.

Dosage and Usage Recommendations

Melatonin is generally recommended at 3 to 6 mg, taken approximately 30 minutes before bedtime, depending on the child’s weight. This treatment is particularly suitable for children who experience chronic sleep-onset insomnia, whether due to ADHD itself or as a side effect of stimulant medications commonly prescribed for ADHD.

Melatonin’s effectiveness in improving sleep quality, without significant adverse effects, makes it a popular choice for managing sleep problems in children with ADHD. However, it is crucial to recognize that melatonin does not address the core symptoms of ADHD and should be considered as part of a broader treatment plan.

Zinc and Iron

Zinc and iron are essential minerals that play vital roles in brain function, particularly in neurotransmitter production and regulation. Deficiencies in these minerals have been linked to ADHD symptoms, and supplementation may help improve these symptoms, especially in deficient children.

Zinc Supplementation and ADHD

Zinc is a cofactor for enzymes crucial for neurotransmitter metabolism and cell membrane stabilization. Zinc deficiency has been associated with symptoms that mimic ADHD, such as inattention and cognitive delays.

Studies conducted in different parts of the world have shown that children with ADHD often have lower zinc levels compared to healthy controls. For example, a study in Turkey demonstrated that 150 mg of zinc sulfate daily significantly improved ADHD symptoms after 12 weeks of treatment. However, the study had a high dropout rate, and the results must be interpreted cautiously.

In contrast, studies conducted in the United States, where zinc deficiency is less common, have shown limited benefits from zinc supplementation. A randomized placebo-controlled trial involving American children with ADHD found no significant differences between zinc supplementation and placebo on ADHD rating scales after eight weeks of treatment.

These mixed results suggest that zinc supplementation may be more effective in populations with a prevalent deficiency. Still, the evidence is insufficient to recommend it as a standard treatment for ADHD in areas where zinc levels are generally adequate.

Iron Supplementation and ADHD

Iron is another essential mineral that plays a critical role in producing dopamine, a neurotransmitter often dysregulated in ADHD. Lower serum ferritin levels, a marker of iron deficiency, have been observed in children with ADHD compared to healthy controls.

A small pilot study involving 23 children with ADHD and low serum ferritin levels found that supplementation with 80 mg of ferrous sulfate daily led to significant improvements in ADHD symptoms after 12 weeks.

While these results are promising, further research is needed to establish whether iron supplementation has any benefits beyond children with diagnosed iron deficiency. For now, iron supplementation should be considered primarily for children with ADHD who have been found to have low iron levels, as excessive iron intake can have adverse effects.

Herbal Supplements

Herbal supplements have gained popularity as alternative treatments for ADHD, though their effectiveness and safety remain subjects of debate. Gingko biloba, St. John’s Wort, and Pycnogenol are the most commonly used herbal remedies. These supplements have been studied to varying degrees, but the evidence supporting their use is limited.

Gingko Biloba

Gingko biloba is often touted as improving cognitive function by promoting brain blood flow and inhibiting platelet activation. However, systematic reviews have not supported its use for cognitive enhancement, including in children with ADHD.

A six-week randomized controlled trial comparing Gingko biloba to methylphenidate (a common ADHD medication) found that while Gingko biloba did lead to some improvement in ADHD symptoms, it was significantly less effective than methylphenidate.

Furthermore, there are concerns about the safety of Gingko biloba, particularly its potential to increase bleeding risk, making it an unadvised option for treating ADHD at this time.

St. John’s Wort

St. John’s Wort, known scientifically as Hypericum perforatum, is another herbal remedy that has been explored as a treatment for ADHD. Similar to some ADHD medications, it is believed to work by inhibiting the reuptake of neurotransmitters like serotonin, norepinephrine, and dopamine.

However, a well-designed, randomized, placebo-controlled trial involving 54 children with ADHD failed to demonstrate any significant benefit from St. John’s Wort compared to placebo over eight weeks of treatment.

Despite its potential biological mechanism, current evidence suggests that St. John’s Wort is no more effective than placebo in treating ADHD. Additionally, it has significant interactions with other medications commonly prescribed for ADHD, depression, and anxiety, further complicating its use.

Pycnogenol

Pycnogenol, an extract from the bark of the French maritime pine, has been studied as a potential treatment for ADHD. Its mechanism of action is not entirely understood, but some studies have suggested that it may improve ADHD symptoms either as a monotherapy or as an adjunct to stimulant medications.

An initial randomized, placebo- and methylphenidate-controlled crossover trial failed to show a significant benefit of Pycnogenol compared to placebo. However, a subsequent four-week randomized, placebo-controlled trial involving 61 children with ADHD did find a significant improvement in ADHD symptoms on specific rating scales. Despite these promising findings, further research is needed to fully evaluate the safety and efficacy of Pycnogenol before it can be recommended as a treatment for ADHD.

Other Nutritional Supplements for ADHD

In addition to polyunsaturated fatty acids, melatonin, zinc, iron, and herbal remedies, several other nutritional supplements have been investigated for their potential role in managing ADHD symptoms. These include magnesium and carnitine, which are widely used despite limited evidence supporting their effectiveness.

Magnesium

Magnesium is a mineral involved in many biochemical processes, including neurotransmitter regulation, which makes it a candidate for treating ADHD. Some case-control studies have shown lower serum magnesium levels in children with ADHD compared to healthy controls. However, randomized, placebo-controlled trials have not demonstrated a significant benefit of magnesium supplementation over placebo in treating ADHD symptoms.

The rationale for using magnesium in ADHD comes from its role as a cofactor for enzymes that interact with monoamine receptors relevant to ADHD. However, the evidence remains inconclusive, and the potential risks of high-dose magnesium, such as toxicity and gastrointestinal side effects, make it a treatment that should be approached with caution.

Carnitine

Carnitine is a small molecule essential for energy production, particularly the oxidation and transport of fatty acids. It has been hypothesized that carnitine might help improve ADHD symptoms by enhancing energy metabolism in the brain.

However, multiple randomized, placebo-controlled trials have failed to demonstrate the efficacy of carnitine supplementation in treating ADHD symptoms. For example, a study involving acetyl-L-carnitine found no significant differences between the supplement and placebo in reducing ADHD symptoms.

Given the lack of evidence supporting its use, carnitine is not currently recommended as an effective treatment for ADHD.

Final Words

While traditional medications remain the most effective treatment for ADHD, many families explore alternative options like nutritional supplements due to concerns about side effects and long-term impacts. Among the supplements discussed, polyunsaturated fatty acids (particularly omega-3s) show the most promise, with evidence supporting their modest effectiveness in improving ADHD symptoms. Melatonin is also beneficial, particularly for addressing sleep problems in children with ADHD, although it does not directly improve core ADHD symptoms.

Zinc and iron supplementation may be helpful for children with deficiencies, but their benefits in non-deficient populations are less clear. Herbal remedies like Gingko Biloba, St. John’s Wort, and Pycnogenol have mixed evidence. Some studies suggest minor benefits, but they generally fall short of the effectiveness seen with conventional treatments. Additionally, the potential risks associated with these herbs should not be overlooked.

Other supplements, such as magnesium and carnitine, have not demonstrated significant benefits in clinical trials and are not recommended as standard treatments for ADHD at this time.

As you consider these options, you must consult with healthcare professionals to determine the best treatment plan for your child. While some supplements may offer benefits, they should be used cautiously and in conjunction with professional medical advice.

FAQs on Supplements for ADHD

Is it safe to give children ADHD supplements?

Generally, yes, but it's essential to consult a healthcare provider before starting any new supplement, especially for children.

Are there any risks associated with ADHD supplements?

Potential risks include interactions with medications and side effects from high doses, so professional guidance is essential.

Can iron deficiency worsen ADHD symptoms?

Yes, iron deficiency is linked to worsened ADHD symptoms, and supplementation may help if levels are low.

What role does zinc play in ADHD management?

Zinc may support neurotransmitter function, potentially improving symptoms like inattention and impulsivity.

References

  • Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 50(10), 991-1000. https://doi.org/10.1016/j.jaac.2011.06.008
  • Gillies, D., Sinn, J. K., Lad, S. S., Leach, M. J., & Ross, M. J. (2012). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews, 2012(7), CD007986. https://doi.org/10.1002/14651858.CD007986.pub2
  • Puri, B. K., & Martins, J. G. (2014). Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 90(5), 179-189. https://doi.org/10.1016/j.plefa.2014.01.004
  • Weiss, M. D., Wasdell, M. B., Bomben, M. M., Rea, K. J., & Freeman, R. D. (2006). Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 45(5), 512-519. https://doi.org/10.1097/01.chi.0000205707.78886.0c
  • Bilici, M., Yildirim, F., Kandil, S., Bekaroğlu, M., Yildirmiş, S., Değer, O., Ulgen, M., Yildiran, A., & Aksu, H. (2004). Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 28(1), 181-190. https://doi.org/10.1016/j.pnpbp.2003.09.034
  • Arnold, L. E., Disilvestro, R. A., Bozzolo, D., Bozzolo, H., Crowl, L., Fernandez, S., Ramadan, Y., Thompson, S., Mo, X., Abdel-Rasoul, M., & Joseph, E. (2011). Zinc for attention-deficit/hyperactivity disorder: Placebo-controlled double-blind pilot trial alone and combined with amphetamine. Journal of Child and Adolescent Psychopharmacology, 21(1), 1-19. https://doi.org/10.1089/cap.2010.0073
  • Konofal, E., Lecendreux, M., Deron, J., Marchand, M., Cortese, S., Zaïm, M., Mouren, M. C., & Arnulf, I. (2008). Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatric Neurology, 38(1), 20-26. https://doi.org/10.1016/j.pediatrneurol.2007.08.014
  • Salehi, B., Imani, R., Mohammadi, M. R., Fallah, J., Mohammadi, M., Ghanizadeh, A., Tasviechi, A. A., Vossoughi, A., Rezazadeh, S. A., & Akhondzadeh, S. (2010). Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: A double-blind, randomized controlled trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(1), 76-80. https://doi.org/10.1016/j.pnpbp.2009.09.026
  • Weber, W., & Newmark, S. (2007). Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatric Clinics of North America, 54(6), 983-1006. https://doi.org/10.1016/j.pcl.2007.09.006
  • Tenenbaum, S., Paull, J. C., Sparrow, E. P., Dodd, D. K., & Green, L. (2002). An experimental comparison of Pycnogenol and methylphenidate in adults with attention-deficit/hyperactivity disorder (ADHD). Journal of Attention Disorders, 6(2), 49-60. https://doi.org/10.1177/108705470200600201
  • Trebatická, J., Kopasová, S., Hradecná, Z., Cinovský, K., Skodácek, I., Suba, J., Muchová, J., Zitnanová, I., Waczulíková, I., Rohdewald, P., & Duracková, Z. (2006). Treatment of ADHD with French maritime pine bark extract, Pycnogenol. European Child & Adolescent Psychiatry, 15(6), 329-335. https://doi.org/10.1007/s00787-006-0538-3
  • Mahmoud, M. M., El-Mazary, A. M., Maher, R. M., & Saber, M. M. (2011). Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder. Italian Journal of Pediatrics, 37, 60. https://doi.org/10.1186/1824-7288-37-60
  • Van Oudheusden, L. J., & Scholte, H. R. (2002). Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 67(1), 33-38. https://doi.org/10.1054/plef.2002.0378